Here are the biggest calls on Wall Street on Monday:
Wells Fargo reiterates Micron as overweight
Wells raised its price target on the stock ahead of earnings later this month.
“Reiterate OW into F3Q26 (6/24); raise est. & PT to $1,220 (was $550), ~9x F2028 EPS. Despite strong stock perf we see continued upside driven by greater confidence in duration of persistent memory tightness, SCA engagements, & MU’s execution.”
Bank of America upgrades Brown-Forman to neutral from underperform
The firm says it’s getting more “constructive” on the beverage stock.
“We are turning more constructive on Brown Forman, following better than expected Q4/FY26 results and consistent delivery on sales through FY26.”
JPMorgan initiates Kontoor Brands as overweight
JPMorgan says the stock is at an inflection point.
“We are initiating coverage of Kontoor Brands (KTB) with an Overweight rating and $90 December 2027 price target.”
Goldman Sachs upgrades W.R. Berkley to buy from neutral
Goldman says it sees “sustainable underwriting activity for the insurance company.
″... we are upgrading commercial insurer WRB to Buy from Neutral, as we think current underwriting margins and ROE are likely more sustainable than expected.”
Canaccord initiates Lantronix as buy
Canaccord says shares of the drones company have plenty of room to run.
“We are initiating coverage on Lantronix Inc. with a BUY rating and a $10.50 price target.”
Bank of America reiterates Apple as buy
The firm says it’s bullish on Apple’s Worldwide Developer’s Conference this week.
“Reiterate Buy on strong capital returns, eventually winner at AI at the edge & optionality from new products/markets.”
Baird upgrades Crocs to outperform from neutral
Baird said in its upgrade of Crocs that a “healthier North American story is emerging.”
“We are adopting a more positive stance, incorporating a higher degree of confidence that positive inflections for Crocs North America and HEYDUDE look sustainable, increasing visibility to a return to healthier total revenue growth in 2H26.”
Jefferies initiates Innovex International as buy
Jefferies says the oil field services and management company is firing on all cylinders.
“We see INVX as well-positioned, driven by: 1) a big-impact, low-ticket, capital light model; 2) balanced NAM/Int’l & offshore mix; 3) inflecting margins; 4) expanding subsea contribution, and 5) strong FCF/balance sheet profile supporting a disciplined, repeatable M&A framework. Initiate at Buy, PT $34.”
Bernstein initiates Blackstone Digital Infrastructure Trust as outperform
Bernstein says the communications infrastructure company has more room to run.
“We are initiating coverage on Blackstone Digital Infrastructure Trust (BXDC) with an Outperform rating and a target price of $26.”
Barclays downgrades Avis-Budget to underweight from equal weight
Barclays says it sees too many negative catalysts.
“Nevertheless, while fundamentals have become favorable, we downgrade CAR to UW from EW and raise our PT to $150 from $95 as we believe the current stock price is not justified even with improved fundamentals.”
Truist initiates Cabot as buy
The firm says the stock is undervalued.
“We believe CBT’s discounted valuation vs peers primarily reflects recent weakness for global carbon black fundamentals impacting the company’s Reinforcement Materials business.”
Goldman Sachs initiates BrightSpring Health Services as buy
Goldman says the home-based care company has “sector learning growth.”
“We initiate coverage of BrightSpring Health Services with a Buy rating and a $71, 12-month price target.”
Citi initiates GMR Solutions as buy
Citi says the emergency medical services company is undervalued.
“We are initiating coverage on GMR Solutions (GMRS) with a Buy/High Risk rating and a $17 target price.”
Piper Sandler initiates Fervo Energy as overweight
Piper says it sees plenty of upside in the geothermal company.
“Despite FRVO soaring nearly 50% since the company’s successful IPO (vs. +2% S&P 500) where the share offering was upsized and price range increased, based on our project level NPV [net present value] valuation methodology, we still see value in the stock, resulting in our $51 PT, representing 35% upside.”
RBC reiterates Nvidia as outperform
RBC says the stock is too attractive to ignore.
“NVDA looks best positioned among peers for 2H26/2027;”
JPMorgan initiates EagleRock Land as overweight
JPMorgan says the Permian company has plenty of positive catalysts ahead.
“We initiate coverage of EagleRock Land, LLC (EROK) with an Overweight rating and December 2026 price target of $25, weighing differentiated growth within a capital-light, Permian-centric land management platform.”
Morgan Stanley initiates Cerebras Systems as overweight
Morgan Stanley says the semiconductor software company is “unique.”
“Starting late last year we have seen increased demand for low latency inference solutions, a category that Cerebras has uniquely addressed with its wafer scale technology for several years. Contracts point to $6 bn in 2028 revenues with potential for upside.”
UBS upgrades Cummins to buy from neutral
UBS says it sees upside for the company’s power division.
“We upgrade CMI to Buy (from Neutral) and raise our PT to $850 from $565. We think double-digit growth in CMI’s Power business, plus a supportive truck outlook and the rollout of new engines with more content, should drive earnings upside over the next two years.”
Piper Sandler upgrades Teleflex to overweight from neutral
Piper says the medtech company is undervalued.
“Inexpensive medtech stocks haven’t been compelling investment ideas ytd, but our upgrade is tied to upside we see for TFX that could materialize through several forms...”
Raymond James upgrades Voya Financial to strong buy from market perform
The firm double upgraded the stock and says it’s bullish either in a merger or standalone scenario.
“Upgrading VOYA to Strong Buy. We see multiple paths to the company re-rating whether it operates on a standalone basis, sells its Stop Loss business to fund share repurchases, or is ultimately acquired.”
Wells Fargo initiates First Tracks Biotherapeutics as overweight
Wells says it likes the biotech company’s pipeline.
“We rate the shares of TRAX Overweight.”
Evercore ISI upgrades Kilroy Realty to outperform from in line
Evercore says the landlord and developer company has a compelling valuation.
“Overall, KRC remains a recovery story tied to high-quality West Coast office assets, but the pace differs meaningfully by market. San Francisco and Bellevue are improving, Seattle is stabilizing, and Los Angeles remains under pressure.”
Wedbush upgrades Cognizant Technology Solutions to outperform from neutral
The firm says the stock is turning a corner.
“We are upgrading Cognizant Technology Solutions from NEUTRAL to OUTPERFORM while raising our price target from $56 to $70, reflecting an ~11x 2027 P/E multiple as we believe that CTSH is turning a corner heading into 2H26.”
Wolfe initiates Interactive Brokers as outperform
Wolfe says the stock is on the “global growth train.”
“IBKR is the only eBroker with a an unconstrained global TAM, supporting more durable long-term account / EPS growth vs. peers. While shares have run over the last 3Y, valuation is undemanding vs. Financials / Tech comps.”
Wolfe upgrades W.P. Carey to outperform from peer perform
Wolfe says it finally sees a path to growth.
“With this report we upgrade WP Carey (WPC) to Outperform with a price target of $85. After years of structural changes that led to earnings dilution, be believe WPC will continue a path of predictable growth.”
Bank of America reiterates SanDisk as buy
The firm raised its price target on SanDisk to $2,100 per share from $1,550.
“Reiterate Buy on valuation, beneficial joint venture partnership, share gains, and long-term potential for industry consolidation.”
Needham upgrades Biogen to buy from hold
Needham says it sees “pipeline optionality.”
“We are upgrading BIIB to a Buy as Biogen is entering a phase of eight Ph 3 readouts through 2029 with the backdrop of an improved outlook for the commercial portfolio.”